Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients

Chinese Journal of Physiology

Volumn 50, Issue 5, 2007, Pages 225-231

  Tsai, Wen Chiuan ^a   Sheu, Lai Fa ^a   Chao, You Chen ^b   Chen, Ann ^a   Chiang, Hung ^c   Jin, Jong Shiaw ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c Taipei Institute of Pathology   (Taiwan)

Author keywords

Colorectal adenocarcinoma; Hai 1; Immunohistochemistry; Matriptase; Microarray

Indexed keywords

LEUKOCYTE ELASTASE INHIBITOR; MATRIPTASE; SERINE PROTEINASE; SPINT1 PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; ARTICLE; ASIAN; CANCER STAGING; CHINA; COLORECTAL TUMOR; ENZYMOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SURVIVAL RATE; TIME;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE ENDOPEPTIDASES; SURVIVAL RATE; TIME FACTORS;

EID: 46649116786     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aimes, R.T., Zijlstra, A., Hooper, J.D., Ogbourne, S.M., Sit, M.L., Fuchs, S., Gotley, D.C., Quigley, J.P. and Antalis, T.M. Endothelial cell serine protease expressed during vascular morphogenesis and angiogenesis. Thromb. Hemost. 89: 561-572, 2003.
2. Allegra, C.J., Paik, S., Colangelo, L.H., Parr, A.L., Kirsch, I., Kim, G., Klein, P., Johnston, P.G., Wolmark, N. and Wieand, H.S. Prognostic value of thymidylate synthase, Ki67, and p53 in patients with Dukes B and C colon cancer: a national cancer institutenational surgical adjuvant breast and bowel project collaborative study. J. Clin. Oncol. 21: 241-250, 2003.
3. Arber, N., Hibshoosh, H., Yasui, W., Neugut, A.I., Hibshoosh, A., Yao, Y., Sgambato, A., Yamamoto, H., Shapira, I., Rosenman, D., Fabian, I., Weinstein, I.B., Tahara, E. and Holt, P.R. Abnormalities in the expression of cell cycle-related proteins in tumors of the small bowel. Cancer Epiderm. Biomar. 8: 1101-1105, 1999.
4. Benaud, C., Dickson, R.B. and Lin, C.Y. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur. J. Biochem. 268: 1439-1447, 2001.
5. Cagir, B., Nagy, M.W., Topham, A., Rakinic, J. and Fry, R.D. Adenosquamous carcinoma of the colon, rectum, and anus: epidemiology, distribution, and survival characteristics. Dis. Colon Rectum. 42: 258-263, 1999.
6. Cerottini, J.P., Caplin, S., Pampallona, S. and Givel, J.C. Prognostic factors in colorectal cancer. Oncol. Rep. 6: 409-414, 1999.
7. Cheng, M.F., Tzao, C., Tsai, W.C., Lee, W.H., Chen, A., Chiang, H., Sheu, L.F. and Jin, J.S. Expression of EMMPRIN and matriptase in esophageal squamous cell carcinoma: Correlation with clinicopathological parameters. Dis. Esophagus 19: 482-6, 2006.
8. Connolly, K.C., Gabra, H., Millwater, C.J., Taylor, K.J., Rabiasz, G.J., Watson, J.E., Smyth, J.F., Wyllie, A.H. and Jodrell, D.I. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res. 59: 2806-2809, 1999.
9. Ferrara, N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treat 36: 127-137, 1995.
10. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82: 4-6, 1990.
11. Gabra, H., Watson, J.E., Taylor, K.J., Mackay, J., Leonard, R.C., Steel, C.M., Porteous, D.J. and Smyth, J.F. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56: 950-954, 1996.
12. Gentile, M., Wiman, A., Thorstenson, S., Loman, N., Borg, A. and Wingren, S. Deletion mapping of chromosome segment 11q24- q25, exhibiting extensive allelic loss in early onset breast cancer. Int. J. Cancer 92: 208-213, 2001.
13. Hemilton, S.R. and Aaltonen, LA. WHO classification of tumors: tumors of the digestive system. Lyon: IRAC press 2000, pp. 105-119.
14. Jacquemier, J., Ginestier, C., Bertucci, F., Jauffret, E.C., Geneix, J. and Birnbaum, D. Tissue microarrays: a powerful tool in transfer and quality control in oncology, Bulletin. Du. Cancer 90: 31-38, 2003.
15. Jin, J.S., Hsieh, D.S., Loh, S.H., Chen, A., Yao, C.W. and Yen, C.Y. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters. Mod. Pathol. 19: 447-452, 2006.
16. Jin, J.S., Cheng, T.F., Tsai, W.C., Sheu, L.F., Chiang, H. and Yu, C.P. Expression of the serine protease, matriptase, in breast ductal carcinoma of Chinese women: correlation with clinicopathological parameters. Histol. Histopathol. 22: 305-309, 2007.
17. Jin, J.S., Chen, A., Hsieh, D.S., Yao, C.W., Cheng, M.F. and Lin, Y.F. Expression of serine protease matriptase in renal cell carcinoma: correlation of tissue microarray immunohistochemical expression analysis results with clinicopathological parameters. Int. J. Surg. Pathol. 14: 65-72, 2006.
18. Jin, X., Hirosaki, T. and Lin, CY. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zemogen by trypsin. J. Cell. Biochem. 95: 632-647, 2005.
19. Kataoka, H., Hamasuna, R., Itoh, H., Kitamura, N. and Koono, M. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res. 60: 6148-6159, 2000.
20. Lam, J.S., Belldegrum, A.S. and Figlin, R.A. Tissue array-based predictions of pathobiology, prognosis and response to treatment for renal cell carcinoma therapy. Clin. Cancer Res. 10: 6304s-6309s, 2004.
21. Lee, J.W., Song, S.Y., Choi, J.J., Lee, S.J., Kim, B.G., Park, C.S., Lee, J.H., Lin, C.Y., Dickson, R.B. and Bae, D.S. Increased expression of matriptase is associated with histopathologic grades of cervical neoplasia. Hum. Pathol. 36: 626-633, 2005.
22. Lee, M.S., Kiyomiya, K.I., Benaud, C., Dickson, R.B. and Lin, C.Y. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells. Am. J. Physiol. Cell Physiol. 288: C932-C941, 2005.
23. Lee, S.L., Dickson, R.B. and Lin, C.Y. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275: 36720-36725, 2000.
24. McKay, J.A., Douglas, J.J., Ross, V.G., Curran, S., Ahmed, F.Y., Loane, J.F., Murray, G.I. and McLeod, H.L. Expression of cell cycle control proteins in primary colorectal tumor does not always predict expression in lymph node metastases. Clin. Cancer Res. 6: 1113-1118, 2000.
25. Oberst, M.D., Singh, B., Ozdemirli, M., Dickson, R.B., Johnson, M.D. and Lin, C.Y. Characterization of matriptase expression in normal human tissue. J. Histochem. Cytochem. 51: 1017-1025, 2003.
26. Oberst, M.D., Johnson, M.D., Dickson, R.B., Lin, C.Y., Singh, B., Stewart, M., Williams, A., Awatif, A.N., Smyth, J.F., Gabra, H. and Sellar, G.C. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin. Cancer Res. 8: 1101-1107, 2002.
27. Oberst, M., Anders, J., Xie, B., Singh, B., Ossandon, M., Johnson, M., Dickson, R.B. and Lin, C.Y. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am. J. Pathol. 158: 1301-1311, 2001.
28. Petersen, S., Thames, H.D., Nieder, C., Petersen, C. and Baumann, M. The results of colorectal cancer treatment by p53 status: a treatment-specific overview. Dis. Colon Rectum 44: 322-334, 2001.
29. Potter, J.D. Colorectal cancer: molecules and population. J. Natl. Cancer Inst. 91: 916-932, 1999.
30. Sasaki, S., Masaki, T., Umetani, N., Futakawa, N., Ando, H. and Muto, T. Characteristics in primary signet-ring cell carcinoma of the colorectum, from clinicopathological observation. Jpn. J. Clin. Oncol. 28: 202-206, 1998.
31. Takeuchi, T., Harris, J.L., Huang, W., Yan, K.W., Coughlin, S.R. and Craik, C.S. Cellular localization of membrane-type II serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275: 26333-26342, 2000.
32. Thomas, G.V., Szigeti, K., Murphy, M., Draetta, G., Pagano, M. and Loda, M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Am. J. Pathol. 153: 681-687, 1998.
33. Tsai, W.C., Chao, Y.C., Lee, W.H., Chen, A., Sheu, L.F. and Jin, J.S. Increasing EMMPRIN and matriptase expression in hepatocellular carcinoma: tissue microarray analysis of immunohistochemical scores with clinicopathological parameters. Histopathology 49: 388-395, 2006.
34. Zhang, Y., Cai, X., Schlegelberger, B. and Zheng, S. Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization. Cytogenet. Cell Genet. 83: 56-57, 1998.